The technology will be incorporated into the company’s SpineJack implant, a minimally invasive device for treatment of vertebral compression factures. The orthopedic cement technology will allow Vexim to expand its presence in vertebroplasty. Injecting cement into the vertebra will also allow surgery to be performed on cases where stabilizing the fracture and eliminating pain are priorities, according to the report.
The system is scheduled to launch simultaneously in Europe and the U.S. in 2014.
More Articles on Devices:
SpineGuard Receives Russian Approval for PediGuard Spine Device
Premia Spine Develops Spine Implant Alternative to Fusion
Zimmer Releases DTO 5.5 Spine Fixation System for Disc Degeneration
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.